ABIVAX (EPA:ABVX) | WebDisclosure

PRESS RELEASE

published on 04/01/2026 at 22:05, 4 months 5 days ago

Abivax publie ses rapports financiers auprès des autorités françaises et américaines de régulation des marchés financiers
Abivax publie ses rapports financiers en France et aux États-Unis pour l'année 2025, incluant le Document d'Enregistrement Universel et le Rapport Annuel (20-F). Informations disponibles sur les sites web d'Abivax, de l'AMF et de la SEC

Abivax Document D'Enregistrement Universel Rapport Annuel Rapports Financiers Autorités Régulation
PRESS RELEASE

published on 04/01/2026 at 22:05, 4 months 5 days ago

Abivax Publishes Financial Reports with the French and U.S. Securities Regulatory Agencies
Abivax publishes financial reports with French and U.S. regulatory agencies, including Universal Registration Document and Annual Report. Company focuses on immune response in chronic inflammatory diseases with lead drug candidate in Phase 3 trials

Abivax Ulcerative Colitis Financial Reports Immune Response Regulatory Agencies
BRIEF

published on 03/27/2026 at 18:05, 4 months 10 days ago

ABIVAX: Details on Share Capital and Voting Rights as of February 28, 2026

Euronext Paris Share Capital Voting Rights Actions Abivax
BRIEF

published on 03/27/2026 at 18:05, 4 months 10 days ago

ABIVAX : Détails sur le Capital Social et les Droits de Vote au 28 février 2026

Euronext Paris Droits De Vote Capital Social Actions Abivax
PRESS RELEASE

published on 03/27/2026 at 18:00, 4 months 10 days ago

ABIVAX: Nombre d’actions composant le capital social et nombre total de droits de vote au 28.02.26.
ABIVAX communique le nombre d'actions et de droits de vote au 28.02.26, conformément aux réglementations financières. ABIVAX est une société de biotechnologie axée sur les traitements des maladies inflammatoires

Droits De Vote Biotechnologie Actions Abivax Maladies Inflammatoires
BRIEF

published on 03/23/2026 at 21:10, 4 months 14 days ago

Abivax présente ses résultats 2025 et ses perspectives

Obefazimod Résultats Financiers 2025 Trésorerie 2027 DSMB ABTECT Nominations Cadres
BRIEF

published on 03/23/2026 at 21:10, 4 months 14 days ago

Abivax presents its 2025 results and outlook

Obefazimod Management Appointments 2025 Financial Results DSMB ABTECT Cash Flow 2027
BRIEF

published on 03/23/2026 at 21:10, 4 months 14 days ago

Abivax Reports Full Year 2025 Financial Results and Business Updates

Financial Results Biotechnology Obefazimod Clinical Trials Leadership Appointments
BRIEF

published on 03/23/2026 at 21:10, 4 months 14 days ago

Abivax publie ses résultats financiers pour l'exercice 2025 et fait le point sur ses activités.

Résultats Financiers Biotechnologie Obefazimod Essais Cliniques Nominations De Dirigeants
PRESS RELEASE

published on 03/23/2026 at 21:05, 4 months 14 days ago

Abivax annonce ses résultats financiers pour l’exercice 2025 et fait le point sur l’avancement de ses activités
Abivax annonce ses résultats financiers pour l’exercice 2025 et fait le point sur l’avancement de ses activités. Nomme de nouveaux cadres dirigeants et annonce des données clés pour l'avenir

Résultats Financiers Abivax DSMB Cadres Dirigeants Avenir

Published on 08/07/2026 at 00:45, 3 hours 51 minutes ago

NXT Energy Solutions Announces Second Quarter 2026 Results
Published on 08/06/2026 at 23:15, 5 hours 21 minutes ago

LNG Energy Group Announces Issuance of Second Partial Revocation Order and Further Details on Private Placement Financing
Published on 08/06/2026 at 22:15, 6 hours 21 minutes ago

Biomind Labs Announces Listing on the Canadian Securities Exchange and the Delisting From the Cboe Canada
Published on 08/06/2026 at 22:05, 6 hours 31 minutes ago

Innodata Reports Record Second Quarter 2026 Results
Published on 08/06/2026 at 22:00, 6 hours 36 minutes ago

Gold Terra Announces Closing of Second Tranche of the C$10.8M LIFE

View all ACCESSWIRE

Published on 08/06/2026 at 22:50, 5 hours 46 minutes ago

Amrize Reports Second Quarter 2026 Results
Published on 08/06/2026 at 22:15, 6 hours 21 minutes ago

BIRKENSTOCK SEEKS TO FILL VACANCY IN THE BOARD OF DIRECTORS WITH AN INDEPENDENT DIRECTOR, FOLLOWING ALEXANDRE ARNAULT'S RESIGNATION DUE TO PROFESSIONAL COMMITTMENTS
Published on 08/06/2026 at 21:45, 6 hours 50 minutes ago

FP Markets Analysis: Japanese Yen at a Crossroads as Markets Weigh Next Move
Published on 08/06/2026 at 19:05, 9 hours 30 minutes ago

Cision Wins 2026 MarTech Breakthrough Awards for Social Listening, Press Release Distribution, and AEO
Published on 08/06/2026 at 18:24, 10 hours 11 minutes ago

EQS-Adhoc: Allgeier SE: Allgeier Increases Revenue by 10 Percent in the First Half of 2026 and Confirms Its Guidance for 2026

View all EQS

Published on 08/06/2026 at 18:26, 10 hours 10 minutes ago

Air Liquide voting rights as of July 31st 2026
Published on 08/06/2026 at 18:26, 10 hours 10 minutes ago

Air Liquide droits de vote au 31 juillet 2026
Published on 08/06/2026 at 17:46, 10 hours 50 minutes ago

Déclaration des droits de vote à fin juillet 2026
Published on 08/06/2026 at 17:45, 10 hours 51 minutes ago

Déclaration des droits de vote à fin juillet 2026
Published on 08/06/2026 at 17:45, 10 hours 51 minutes ago

Declaration of voting rights at the end of July 2026

View all LES ECHOS COMFI WIRE

News